165 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
and security laws and regulations regarding the collection, use, storage, retention, disclosure, transfer, disposal, or any other processing
8-K
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
by the ARCA’s board of directors, and (c) a retention bonus of $165,000.
In addition, Mr. Dekker has entered into a consulting agreement with the Company
8-K
EX-10.10
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
to the grant, issuance, retention, vesting, exercisability or settlement of any Award;
(vii) to prescribe and amend the terms of or form of any document … pursuant to an Award or in settlement thereof.
8. Options
(a) Grant, Term and Price. The grant, issuance, retention, vesting and/or settlement
8-K
EX-99.5
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
and retention bonus payments for certain non-executives, the aggregate of which was treated as pre-merger compensation expense of ARCA and was reflected … compensation expense of $1.5 million related to severance, retention bonuses and change in control payments resulting from pre-existing employment agreements
424B3
ORKA
Oruka Therapeutics Inc.
1 Aug 24
Prospectus supplement
4:10pm
under certain conditions related to a change in control of the Company.
In December 2022, the Company’s Board of Directors approved retention … clinical development decisions totaling $265,000. In November 2023, the retention bonuses were amended to increase the aggregate amount of the retention
8-K
EX-10.2
fuiaz6o k04xq
23 Apr 24
Departure of Directors or Certain Officers
4:20pm
8-K
EX-10.1
7sgprr du0t1s5p
23 Apr 24
Departure of Directors or Certain Officers
4:20pm
8-K
f90g0mrfo1l4x
23 Apr 24
Departure of Directors or Certain Officers
4:20pm
8-K
EX-10.1
0sbq97
4 Apr 24
Departure of Directors or Certain Officers
4:30pm
425
93ttnwxy1qz6i8c9c
3 Apr 24
Business combination disclosure
7:33am
8-K
EX-2.1
4ij627gw2z7l p6xwx
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am
8-K
EX-10.1
228fejhzzw1hn 76lww
4 Dec 23
Departure of Directors or Certain Officers
4:36pm